Addressing Regulatory Challenges in Clinical Trials of Cannabis-Related Drug Products


In the following article in the Journal for Clinical Studies, Aman Khera, Barry J. Dussault, and Henry J. Riordan write about regulatory and operational considerations with the recent global interest in developing therapies related to cannabis.

Questions regarding your upcoming clinical trial?